ロード中...
Chromosomal microarray analysis for pregnancies with abnormal maternal serum screening who undergo invasive prenatal testing
Recently, chromosomal microarray analysis (CMA) has been implemented as a first‐tier test in pregnancies with ultrasound anomalies. However, its application for pregnancies with abnormal maternal serum screening (AMSS) only is not widespread. This study evaluated the value of CMA compared to traditi...
保存先:
| 出版年: | J Cell Mol Med |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8256361/ https://ncbi.nlm.nih.gov/pubmed/34042265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16589 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|